Brief: Arca Biopharma Posts Q2 Loss Per Share Of $0.34
04/08/2021 22:49
Aug 4 (Reuters) - ARCA Biopharma Inc ABIO.O :
* ARCA BIOPHARMA ANNOUNCES SECOND QUARTER 2021 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
* Q2 LOSS PER SHARE $0.34
* ARCA BIOPHARMA - BELIEVES CURRENT CASH AND CASH
EQUIVALENTS WILL
BE SUFFICIENT TO FUND OPERATIONS THROUGH 2022
Source text for Eikon: ID:nGNX4g0Vpl
Further company coverage: ABIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oruka Therapeutics
See all newsOruka falls after reporting mid-stage data for psoriasis drug
Brief: Oruka Therapeutics Announces Positive Week 28 Data For Orka-001 From The Ongoing Everlast-A Trial Showing Deepening Of Responses Without Additional Dosing
Brief: Oruka Therapeutics Appoints Todd Edwards As Chief Commercial Officer
U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna Therapeutics
Oruka Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary